LEE011, Letrozole, BYL719 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-02-26 in 4mo
ESTIMATED |
READOUT
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
Phase 1/2 · Breast Cancer |
NVS NOVARTIS AG | LEE011, Letrozole, BYL719 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-10-23
Sponsor-projected date — can change
|